Wilson Sonsini Goodrich & Rosati advised Replace Therapeutics on the transaction.Tome Biosciences, Inc., a programmable genomic integration (PGI) company, announced that it has acquired Replace Therapeutics…
Tome Biosciences’ Acquisition of Replace Therapeutics
